Modify Therapeutics was a biotechnology company that focused on the development of antibody therapeutics targeting hard-to-treat inflammatory diseases, with a specific focus on…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Modify Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Modify Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.